Recent activity at Virginia Department of Environmental Quality
Meetings, budgets, and plans from this organization.
Jan 21, 2027·Board meeting agenda
Virginia's Department of Medical Assistance Services Pharmacy and Therapeutics Committee Committee Meeting
The meeting focuses on the Pharmacy and Therapeutics Committee's responsibilities, including a review of new drugs for the Preferred Drug List (PDL) and annual class reviews. The agenda encompasses detailed evaluations of various therapeutic classes, such as blood modifiers, central nervous system agents, endocrine and metabolic agents, and immunological agents. Additionally, the committee will engage in a confidential pricing discussion, PDL recommendations, votes, and potential criteria discussions.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Virginia Board Of Nursing Agency Subordinate Informal Conference
The informal conference addressed a series of case reviews for various nursing professionals. These proceedings were conducted as part of the agency's efforts to ensure safe and competent patient care by enforcing standards of practice and reviewing licensure status for health practitioners.
Dec 10, 2026·Board meeting agenda
Virginia Medicaid Drug Utilization Review Board Agenda
The board meeting agenda includes the review of various traditional non-physician administered drugs, such as Baxfendy, Beqalzi, Carbaglu, Etcamah, and others, as well as a selection of Physician Administered Drugs including Fayuvi, Genglycos, and Otarmeni. Additional discussion topics include a Leucovorin trend analysis, the quarterly newsletter, the Prime Therapeutics quarterly pipeline report, and various operational reports covering ProDUR, RetroDUR activity, and utilization analysis.
Dec 3, 2026·Board meeting agenda
Board Of Pharmacy Tentative Agenda
The agenda details a schedule of informal conferences conducted by the Special Conference Committee. The sessions include specific hearings for CVS Pharmacy #1957, Davinder Khalon, and Sheivone Yearwood.
